Mini-liver research to reduce animal use in science
Research that has for the first time successfully grown "mini-livers" from adult mouse stem cells has won the UK #39;s international prize for the scientific and...
By: National Centre for the 3Rs
See the article here:
Mini-liver research to reduce animal use in science - Video
New York, New York (PRWEB) February 26, 2014
Adler Footcare of Greater New York is offering an advanced treatment option for chronic foot problems like plantar fasciitis, as well as common foot problems like Osteoarthritis, Achilles tendonitis and torn soft tissue.
In the past these conditions have been treated by physical therapy or orthotic therapy, but the results have often been poor, leaving patients continuing to struggle with the pain. With stem cell replacement therapy, the treatment of these conditions is proving far more effective and long lasting than traditional treatments.
At Adler Footcare we use live birth stem cells which are introduced into the affected area. Stem cells are used by many physicians to treat a broad variety of conditions because of their ability to either replicate themselves, or change into the cell type that is needed to repair the tissue that has been damaged. When a patient comes in for stem cell therapy, the affected area is carefully measured so the stem cells can be delivered directly to the area that needs the treatment.
The Joint Commission accredited Podiatric OR of Midtown Manhattan housed within Adler Footcare is designed to facilitate advanced treatments such as Stem Cell Replacement Therapy to all their patients.
With stem cell treatment we are finding that patients heal much faster and are able to return to their normal activities much sooner than with traditional treatment options, said Dr. Darline Kulhan, podiatric surgeon at Adler Footcare. Recovery time depends on each individual patients medical diagnosis and overall general health.
Treatments using stem cells have been used by physicians for over 100 years. Stem Cell Replacement Therapy is covered by commercial insurance and Medicare, and is approved and regulated by the FDA. The product is tested and screened by medical professionals to eliminate the potential of any communicable diseases.
To learn more about Stem Cell Replacement Therapy or to schedule a consultation with a New York podiatrist at Adler Footcare, call (212) 704-4310 or visit http://www.mynycpodiatrist.com.
About Adler Footcare New York
Dr. Jeffrey L. Adler, Medical/Surgical Director and owner of Adler Footcare New York has been practicing podiatric medicine since 1979 and has performed thousands of foot and ankle surgeries. Dr. Adler is board certified in Podiatric Surgery and Primary Podiatric Medicine by the American Board of Multiple Specialties in Podiatry. Dr. Adler is also a Professor of Minimally Invasive Foot Surgery for the Academy of Ambulatory Foot and Ankle Surgeons. As one of only several in the country who perform minimally invasive podiatric surgery, Dr. Adlers patients enjoy significantly reduced recovery times.
Continue reading here:
Stem Cell Replacement Therapy for Common Foot Injuries Provides Rapid Healing
ABC 7 LA - Experimental Treatment Uses Stem Cells to Regenerate Discs
Watch this story about how Arizona Pain is helping patients using stem cells. Check out our Stem Cell page: http://arizonapain.com/stemcell/ for more informa...
By: Arizona Pain
Read more:
ABC 7 LA - Experimental Treatment Uses Stem Cells to Regenerate Discs - Video
Future of Pain Relief: Stem Cells
Allegheny Health Network sports medicine and orthopaedic specialists Dr. Edward Snell and Dr. Patrick DeMeo discuss the benefits and challenges of using stem...
By: Allegheny Health Network
Read the rest here:
Future of Pain Relief: Stem Cells - Video
Sirtuin regulation of metabolism and stem cells - Danica Chen
The metabolic network is coordinately regulated in response to nutritional status to maintain homeostasis. Perturbed metabolic homeostasis is integral to the...
By: SENS Foundation
Originally posted here:
Sirtuin regulation of metabolism and stem cells - Danica Chen - Video
Frederick, MD (PRWEB) February 25, 2014
RoosterBio Inc is a new biotech start-up supplying human bone marrow-derived Mesenchymal Stem Cells (hBM-MSC) for tissue engineering research and stem cell-based product development into the high growth Synthetic Biology and Regenerative Medicine fields. RoosterBio, Inc. initiated laboratory operations in October, 2013, and has achieved the critical milestone of first product shipment to paying customers in just four short months. In addition to the early validation of their business model and rapidly generating revenue, Roosterbio has raised over 250K in seed investment and are actively seeking funds via AngelList (https://angel.co/roosterbio).
RoosterBio credits their quick-to-market accomplishments to hyper-efficient operations and the passion that the RoosterBio team shares in their desire to assist tissue engineers and cell therapists to accelerate life-saving technologies into the clinic. Our laser focus coupled with operational excellence has enabled us to reach these milestones; we will delight our customers with our product offering, says Chief Operating Officer, Dr. Uplaksh Kumar. The RoosterBio teams extensive experience sourcing raw materials, manufacturing stem cell products, and controlling for high quality with best-in-class characterization techniques has allowed them to successfully launch their flagship hBM-MSC product quickly and efficiently.
Dr. Jon Rowley, RoosterBios Chief Executive said I cant express how proud I am of our small, highly dedicated team that worked tirelessly to get our first products designed, manufactured, quality tested, released, and just as importantly sold and shipped to our first paying customers. This was truly a team effort that couldnt have been done without each and every person at RoosterBio.
Having spent years as cell and tissue technologists, the RoosterBio team has an intimate understanding of the pain points surrounding the generation of large numbers of robust, reproducible, standardized cells for research and product development purposes. RoosterBio products are designed to solve this problem and they believe that high volume and affordable cellular raw materials will kick-start the cell-based medical product revolution.
Dr. Sarah Griffiths, a Researcher at Georgia Tech in Atlanta, believes that RoosterBios MSCs will do exactly that, and was anxiously awaiting receipt of the product. "We are excited to receive the first shipment of RoosterBios product. The potential to generate large stocks of MSCs in a short period of time will be a tremendous advantage to the progress of our research."
Researchers in the fields of Synthetic Biology and Regenerative Medicine, such as Dr. Griffiths, will use RoosterBios MSCs to develop new medical therapies to provide treatments for degenerative diseases such as Parkinsons and Alzheimers diseases, or to repair or replace tissue after a catastrophic injury such as traumatic bone and cartilage injury, spinal cord damage, heart attack, or significant burns.
RoosterBios current focus is to supply high volume research-grade cells manufactured with processes consistent with current Good Manufacturing Practices (cGMP). They are rapidly approaching their next milestones by laying the groundwork for initiating production of clinical-grade cells to be used in translational R&D and clinical studies.
About RoosterBio RoosterBio is focused on building a robust and sustainable Regenerative Medicine industry. Our products are affordable and standardized primary cells and media, manufactured and delivered with highest quality and in formats that simplify product development efforts. RoosterBio products are made with care in Frederick, MD, and will accelerate the translation of cell therapy and tissue engineering technologies into the clinic.
Continued here:
RoosterBio Inc, a Frederick Maryland Biotech Startup, Achieves Rapid Traction with Product Launch and Fundraising ...
Spontaneously contracting former stem cells
By: Michelle Sener
Read this article:
Spontaneously contracting former stem cells - Video
Richfeel Anagrow: World #39;s First Hair Thinning Treatment With Plant Stem Cell!
The Richfeel Anagrow treatment is the first of its kind in the world of hair care using "PCT Rejuva Max having Plant stem extracts and RF Anagrow 10X the fir...
By: Richfeel Trichology
See original here:
Richfeel Anagrow: World's First Hair Thinning Treatment With Plant Stem Cell! - Video
Stem cells from osteoarthritis patients as good as controls
http://wwwarthritistreatmentcenter.com Stem cells from patients with osteoarthritis are as good as normal controls Alwin Scharstuhl and colleagues, in an art...
By: Nathan Wei
Read more:
Stem cells from osteoarthritis patients as good as controls - Video
- Rheumatoid Arthritis and Parkinsons: Stem cell treatment
A patient was suffering from Rheumatoid Arthitis Parkinsons and was treated by Stem cell therapy.After the treatment Patient is able to walk fast.
By: Dr. Pradeep Mahajan
Originally posted here:
- Rheumatoid Arthritis and Parkinsons: Stem cell treatment - Video
The power of regenerative medicine now allows scientists to transform skin cells into cells that closely resemble heart cells, pancreas cells and even neurons. However, a method to generate cells that are fully mature -- a crucial prerequisite for life-saving therapies -- has proven far more difficult. But now, scientists at the Gladstone Institutes and the University of California, San Francisco (UCSF), have made an important breakthrough: they have discovered a way to transform skin cells into mature, fully functioning liver cells that flourish on their own, even after being transplanted into laboratory animals modified to mimic liver failure.
In previous studies on liver-cell reprogramming, scientists had difficulty getting stem cell-derived liver cells to survive once being transplanted into existing liver tissue. But the Gladstone-UCSF team figured out a way to solve this problem. Writing in the latest issue of the journal Nature, researchers in the laboratories of Gladstone Senior Investigator Sheng Ding, PhD, and UCSF Associate Professor Holger Willenbring, MD, PhD, reveal a new cellular reprogramming method that transforms human skin cells into liver cells that are virtually indistinguishable from the cells that make up native liver tissue.
These results offer new hope for the millions of people suffering from, or at risk of developing, liver failure -- an increasingly common condition that results in progressive and irreversible loss of liver function. At present, the only option is a costly liver transplant. So, scientists have long looked to stem cell technology as a potential alternative. But thus far they have come up largely empty-handed.
"Earlier studies tried to reprogram skin cells back into a pluripotent, stem cell-like state in order to then grow liver cells," explained Dr. Ding, one of the paper's senior authors, who is also a professor of pharmaceutical chemistry at UCSF, with which Gladstone is affiliated. "However, generating these so-called induced pluripotent stem cells, or iPS cells, and then transforming them into liver cells wasn't always resulting in complete transformation. So we thought that, rather than taking these skin cells all the way back to a pluripotent, stem cell-like state, perhaps we could take them to an intermediate phase."
This research, which was performed jointly at the Roddenberry Center for Stem Cell Research at Gladstone and the Broad Center of Regeneration Medicine and Stem Cell Research at UCSF, involved using a 'cocktail' of reprogramming genes and chemical compounds to transform human skin cells into cells that resembled the endoderm. Endoderm cells are cells that eventually mature into many of the body's major organs -- including the liver.
"Instead of taking the skin cells back to the beginning, we took them only part way, creating endoderm-like cells," added Gladstone and CIRM Postdoctoral Scholar Saiyong Zhu, PhD, one of the paper's lead authors. "This step allowed us to generate a large reservoir of cells that could more readily be coaxed into becoming liver cells."
Next, the researchers discovered a set of genes and compounds that can transform these cells into functioning liver cells. And after just a few weeks, the team began to notice a transformation.
"The cells began to take on the shape of liver cells, and even started to perform regular liver-cell functions," said UCSF Postdoctoral Scholar Milad Rezvani, MD, the paper's other lead author. "They weren't fully mature cells yet -- but they were on their way."
Now that the team was encouraged by these initial results in a dish, they wanted to see what would happen in an actual liver. So, they transplanted these early-stage liver cells into the livers of mice. Over a period of nine months, the team monitored cell function and growth by measuring levels of liver-specific proteins and genes.
Two months post-transplantation, the team noticed a boost in human liver protein levels in the mice, an indication that the transplanted cells were becoming mature, functional liver cells. Nine months later, cell growth had shown no signs of slowing down. These results indicate that the researchers have found the factors required to successfully regenerate liver tissue.
Read the original post:
Skin cells transformed into functioning liver cells in mouse study
UCL Biochemical Engineering, Pilot Plant Week 2014, Group 1- Stem Cells
Nothing - Cat Empire http://www.youtube.com/watch?v=MDhil5vSsFE With Thanks, to UCL Biochemical Engineering.
By: UCL BiochemEng
Read more:
UCL Biochemical Engineering, Pilot Plant Week 2014, Group 1- Stem Cells - Video
Cloning: 1st Place Sci Vis at Florida TSA State Conference
This video explores both reproductive and therapeutic cloning, from somatic cell nuclear transfer to modern concerns about stem cells. All scenes are origina...
By: Adrian Traviezo
Continue reading here:
Cloning: 1st Place Sci Vis at Florida TSA State Conference - Video
Medeniyet Konferansn "nsan Kanser Kk Hcreleri (Human Cancer Stem Cells: Fact or Fiction)"
12 ubat 2014 tarihinde niversitemiz Gztepe-Kuzey Yerlekesinde gerekleen konferansta Dr. James A. Radosevich #39;in, "nsan Kanser Kk Hcreleri (Human Canc...
By: MU NVERSTES
Continue reading here:
Medeniyet Konferansn "nsan Kanser Kk Hcreleri (Human Cancer Stem Cells: Fact or Fiction)" - Video
Are stem cells from osteoarthritis patients able to differentiate
http://www.arthritistreatmentcenter.com Are stem cells in patients with osteoarthritis less able to differentiate? J Mary Murphy and colleagues published an ...
By: Nathan Wei
Original post:
Are stem cells from osteoarthritis patients able to differentiate - Video
Atheist Community of San Jose: Uta Grieshammer on The Remarkable Powers of Stem Cells
Did you know that without stem cells you would not be able to absorb any food, you wouldn #39;t have any skin and there would be no blood coursing through your v...
By: SanJoseAtheists
Go here to see the original:
Atheist Community of San Jose: Uta Grieshammer on The Remarkable Powers of Stem Cells - Video
What is Embryonic Stem Cells? (Chinese)
Like us at https://www.facebook.com/puredeerpurtier.
By: purtierbecca
Here is the original post:
What is Embryonic Stem Cells? (Chinese) - Video
Cambridge News Follow us on
Sunday 23 Feb 2014 10:30 AM
Written byELEANOR DICKINSON
Sufferers of serious brain diseases could one day be helped by stem cell treatments , according to scientists at Cambridge University.
Scientists at the University hope to be able to use the regenerative power of stem cells to treat major brain conditions such as Parkinsons and Huntingtons disease.
Their findings are expected to be revealed at the Cambridge Festival of Science next month.
Robin Franklin, the newly appointed Professor of Stem Cell Medicine, will be discussing his research into central nervous system regeneration and the possibility of treating multiple sclerosis.
He said: The brain, although capable of unmatched feats of adaptability, is generally considered to be an organ that is very poor at mending itself after injury.
However, one particular type of brain cell, called the oligodendrocyte the cell that makes the myelin wrapping around nerve fibres can be regenerated when lost in disease by the brains own stem cells.
By studying in the laboratory how brain stem cells generate new oligodendrocytes it has been possible to identify ways in which this important regenerative process might be achieved in the clinic, offering the
More:
Stem cells to fight brain diseases say Cambridge scientists
Arthritic knees treated with stem cells by Dr Harry Adelson - 18 months after treatment
Linda discusses her outcome of the stem cell treatment she received from Dr Harry Adelson for her arthritic knees.
By: Harry Adelson, N.D.
See original here:
Arthritic knees treated with stem cells by Dr Harry Adelson - 18 months after treatment - Video
Spontaneous Contracting Former Stem Cells
By: Michelle Sener
See the original post:
Spontaneous Contracting Former Stem Cells - Video